Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
ContextLogic Inc. - Class A Common Stock
(NQ:
LOGC
)
7.060
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jun 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ContextLogic Inc. - Class A Common Stock
< Previous
1
2
3
4
Next >
12 Consumer Discretionary Stocks Moving In Monday's Intraday Session
June 02, 2025
Via
Benzinga
Which stocks are gapping on Monday?
June 02, 2025
Today's session on Monday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
SAIC, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
June 02, 2025
Via
Benzinga
These stocks that are showing activity before the opening bell on Monday.
June 02, 2025
Let's have a look at what is happening on the US markets before the opening bell on Monday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
An Overview of ContextLogic's Earnings
May 08, 2025
Via
Benzinga
Looking Into LogicBio Therapeutics's Recent Short Interest
October 03, 2022
LogicBio Therapeutics's (NASDAQ:LOGC) short percent of float has fallen 62.5% since its last report. The company recently reported that it has 29 thousand shares sold short, which is 0.12% of all...
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session
June 02, 2025
Via
Benzinga
Why Blueprint Medicines Shares Are Trading Higher By 27%; Here Are 20 Stocks Moving Premarket
June 02, 2025
Via
Benzinga
12 Consumer Discretionary Stocks Moving In Friday's After-Market Session
May 30, 2025
Via
Benzinga
Friday's after hours session: top gainers and losers
May 30, 2025
After the closing bell on Friday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
Via
Chartmill
Earnings Scheduled For May 9, 2025
May 09, 2025
Via
Benzinga
ContextLogic Slips Aftermarket On Q4 Earnings Miss: Retail’s Cautious
March 13, 2025
Sentiment on Stocktwits ended ‘neutral’ on Wednesday compared to ‘bearish’ a day ago.
Via
Stocktwits
ContextLogic Stock Sees Retail Chatter Spike On BC Partners' Investment Ahead Of Q4 Results
March 02, 2025
Under the deal, BC Partners planned to buy up to $150 million of convertible preferred units, a newly-formed Delaware limited liability company and a wholly-owned subsidiary of the company.
Via
Stocktwits
Earnings Scheduled For March 12, 2025
March 12, 2025
Via
Benzinga
ContextLogic And BC Partners Forge $150 Million Strategic Partnership For Growth
February 25, 2025
BC Partners invests $150M in ContextLogic, providing access to $300M in capital. New board members to maximize shareholder value and drive growth.
Via
Benzinga
LOGC Stock Earnings: ContextLogic Misses EPS, Beats Revenue for Q2 2024
August 09, 2024
LOGC stock results show that ContextLogic missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via
InvestorPlace
11 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
July 04, 2024
Via
Benzinga
Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday
October 04, 2022
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per...
Via
Benzinga
Nasdaq Jumps 270 Points; Silver Surges Over 8%
October 03, 2022
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite climbing around 270 points on Monday.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
October 03, 2022
Gainers
Via
Benzinga
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
October 03, 2022
Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share.
Via
Benzinga
S&P 500 Surges 2%; Crude Oil Rises Sharply
October 03, 2022
U.S. stocks extended gains midway through trading, with the Dow Jones gaining more than 600 points on Monday.
Via
Benzinga
GLSI, APRN: The Top 5 Short Squeeze Stocks to Watch This Week
October 03, 2022
Investors are still interested in short squeeze stocks lately and we've got them covered with the ones to watch this week!
Via
InvestorPlace
Blue Apron (APRN) Stock Falls 33% on CFO Departure, Stock Sale
October 03, 2022
Blue Apron (APRN) stock is sliding lower on Monday as investors react to its CFO leaving the company and plans for a stock sale.
Via
InvestorPlace
Why Is LogicBio (LOGC) Stock Up 600% Today?
October 03, 2022
LogicBio (LOGC) stock is seeing massive gains on Monday following news that AstraZeneca (AZN) subsidiary Alexion is acquiring the company.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 03, 2022
Gainers LogicBio Therapeutics (NASDAQ:LOGC) shares moved upwards by 641.3% to $2.02 during Monday's pre-market session. The company's market cap stands at $66.5 million.
Via
Benzinga
Why LogicBio Therapeutics Stock Is Soaring Today
October 03, 2022
LogicBio Therapeutics Inc (NASDAQ: LOGC) shares are trading higher Monday after the company announced it will be acquired by AstraZeneca PLC (NASDAQ: AZN) subsidiary Alexion for $2.07 per share.
Via
Benzinga
Why Are LogicBio Therapeutics Shares Skyrocketing Today?
October 03, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
September 19, 2022
Gainers Reshape Lifesciences (NASDAQ:RSLS) stock increased by 10.1% to $0.39 during Monday's after-market session. The company's market cap stands at $1.3 million.
Via
Benzinga
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
August 17, 2022
Gainers Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.